UC Treatment: Anti-integrin Antibodies and Anti-interleukins
David P. Hudesman, MD, reviews the use of anti-integrin and anti-interleukin therapies for the management of ulcerative colitis.
Read More
Using 5-ASAs and Steroids for UC Treatment
Ellen J. Scherl, MD, comments on the limited role of mesalamine and steroids for moderate-to-severe ulcerative colitis treatment.
Approaching Ulcerative Colitis Treatment Selection
Marla Dubinsky, MD, emphasizes the role of shared decision-making and patient goals of therapy when approaching treatment selection for ulcerative colitis.
Impact of IBD on Quality of Life
Drs David P. Hudesman, Marla Dubinsky, and Ellen J. Scherl explore the impact of IBD and ulcerative colitis on a patient’s quality of life.
Disease Subtypes and Differential Diagnosis of UC and CD
Ellen J. Scherl, MD, highlights the different subtypes of ulcerative colitis and the differential diagnosis with Crohn’s disease.
Overview of Inflammatory Bowel Disease (IBD)
David P. Hudesman, MD, and Marla Dubinsky, MD, define symptoms and potential disease triggers for inflammatory bowel disease (IBD).